199 related articles for article (PubMed ID: 6232315)
21. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
[TBL] [Abstract][Full Text] [Related]
22. OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules.
Strassman G; Bach FH
J Immunol; 1984 Oct; 133(4):1705-9. PubMed ID: 6332131
[TBL] [Abstract][Full Text] [Related]
23. In vitro effects of solubilized HLA-DR--role in immunoregulation?
Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
[TBL] [Abstract][Full Text] [Related]
24. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
[TBL] [Abstract][Full Text] [Related]
25. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
Palacios R
J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
[TBL] [Abstract][Full Text] [Related]
26. Differential requirements for class II MHC antigen in human T cell activation.
Goeken NE; Eckerle MK; Lioubin PJ; Staggs TS
Transplantation; 1984 Dec; 38(6):714-9. PubMed ID: 6438845
[TBL] [Abstract][Full Text] [Related]
27. Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions.
Engleman EG; Benike CJ; Charron DJ
J Exp Med; 1980 Aug; 152(2 Pt 2):114s-126s. PubMed ID: 6447741
[TBL] [Abstract][Full Text] [Related]
28. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
29. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
30. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
31. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH
Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
[TBL] [Abstract][Full Text] [Related]
32. Induction of primary T cell responses by human glial cells.
Williams K; Ulvestad E; Cragg L; Blain M; Antel JP
J Neurosci Res; 1993 Nov; 36(4):382-90. PubMed ID: 7903705
[TBL] [Abstract][Full Text] [Related]
33. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
34. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
35. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition.
Yamada K; Sachs DH; DerSimonian H
J Immunol; 1995 Dec; 155(11):5249-56. PubMed ID: 7594537
[TBL] [Abstract][Full Text] [Related]
36. Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.
Paroli M; Carloni G; Franco A; De Petrillo G; Alfani E; Perrone A; Barnaba V
Immunology; 1994 Jun; 82(2):215-21. PubMed ID: 7927492
[TBL] [Abstract][Full Text] [Related]
37. Suppression of the mixed lymphocyte reaction by alloantigen-primed and -stimulated human spleen lymphocytes.
Akbar AN; Jones DB
Immunology; 1984 Feb; 51(2):361-6. PubMed ID: 6229476
[TBL] [Abstract][Full Text] [Related]
38. [Kinetics of the appearance of HLA-DR antigens on human alloactivated T lymphocytes and the demonstration of new antigenic determinants].
Wollman EE; Lepage V; Delima M; Fradelizi D; Degos L; Dausset J
C R Seances Acad Sci D; 1980 Nov; 291(9):757-61. PubMed ID: 6162584
[TBL] [Abstract][Full Text] [Related]
39. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.
Engleman EG; Charron DJ; Benike CJ; Stewart GJ
J Exp Med; 1980 Aug; 152(2 Pt 2):99s-113s. PubMed ID: 6967944
[TBL] [Abstract][Full Text] [Related]
40. Cloned human T lymphocytes with lymphostimulatory capacity preferentially activate suppressor cells.
Pawelec G; Schneider EM; Wernet P
Eur J Immunol; 1984 Apr; 14(4):335-40. PubMed ID: 6233155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
